Description
Molecular imaging involves the ability to generate images of specific molecules within the body.
The versatility of medical imaging modalities is continuing to increase as care givers keep older people alive longer. Age-related diseases such as cancer, stroke and heart disease represent the highest cost burden to health care in developed countries.
Kalorama Information has been noting developments in these technologies and rendering the market for them visible to market watchers and business planners. Medical Imaging Markets: Molecular Imaging offers complete market coverage of world markets for molecular imaging products for the following technologies:
- PET
- SPECT-Gamma Camera Systems
- MRI
- CT
- Ultrasound
- SPECT/CT
- PET/CT
For each of these modalities, the report provides current market size based on revenues to manufacturers of imaging systems used for molecular procedures, as well as forecasts of future revenues.
Interest in and use of the technology has exploded in recent years, thanks to advances in cell biology, biochemical agents, and computer analysis, and serious market watchers in medical imaging industries, as well as those serving or investing in medical imaging companies, will want to keep abreast of this new market. As part of its comprehensive coverage, Medical Imaging Markets: Molecular Imaging includes:
- Overview and Explanation of modalities and key applications
- Over 25 Figures and Tables to make market data accessible to users
- Review of Imaging Agents in Clinical Trials, or that are recently introduced
- Market Size and Forecasts are developed through 2014
- Profiles of Top Competitors in the industry
Kalorama looks at the technologies currently used in molecular imaging but also examines novel research areas, such as:
- Heart Failure
- Breast Biopsies
- Treating Thyroid Cancer
- Molecular Events
- Nanoparticle Platform
- Detecting Circulating Progenitor Cells
- Molecular Level Tumor Activity
- Brain Cell Inflammatory Response
- Hybrid Scanner
- Semiconductor-Based PET Scanner
- PET Scanning Coverage
- Motion-Frozen Technology
- Recurring Prostate Cancer
- Bone Imaging Alternatives
- New Perfusion Tracer
Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data provide multiple year forecasts for different product segments covered in the report. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives, clinicians and researchers.
Table of Contents
TABLE OF CONTENTS
1.0 Executive Summary
- 1.1 Molecular Basis of Cell Function
- 1.2 Driving Healthcare
- 1.3 Two Components
- 1.4 Key Modalities
- 1.5 World Market Summary
- 1.5.1 Market Drivers and Challenges
- 1.5.2 Growth Analysis
- 1.6 Methodology
2.0 Introduction
- 2.1 Definition
- 2.1.1 For Diagnosis
- 2.1.1.1 Molecular Agents
- 2.2 New Direction for Medicine
- 2.3 Modalities and Applications
- 2.3.1 Nuclear Medicine
- 2.3.1.1 PET
- 2.3.1.2 SPECT and Gamma Cameras
- 2.3.2 CT
- 2.3.3 MRI
- 2.3.4 Ultrasound
- 2.3.5 Fusion Imaging
- 2.3.5.1 PET/CT
- 2.3.5.2 SPECT/CT
- 2.4 Optical Imaging
- 2.5 Drivers
- 2.6 Issues and Challenges
- 2.7 Health Care Reform
3.0 Research with Potential
- 3.1 Heart Failure
- 3.2 Breast Biopsies
- 3.3 Treating Thyroid Cancer
- 3.4 Molecular Events
- 3.5 Nanoparticle Platform
- 3.6 Detecting Circulating Progenitor Cells
- 3.7 Molecular Level Tumor Activity
- 3.8 Brain Cell Inflammatory Response
- 3.9 Hybrid Scanner
- 3.10 Semiconductor-Based PET Scanner
- 3.11 PET Scanning Coverage
- 3.12 Motion-Frozen Technology
- 3.13 Recurring Prostate Cancer
- 3.14 Bone Imaging Alternatives
- 3.15 New Perfusion Tracer
4.0 Markets
- 4.1 Overview
- 4.2 Procedures
- 4.3 Forecasts
- 4.3.1 PET (US/World/Installed Base)
- 4.3.2 SPECT-Gamma Camera Systems (US/World/Installed Base)
- 4.3.3 MRI (US/World)
- 4.3.4 CT (US/World)
- 4.3.5 Ultrasound (US/World)
- 4.3.6 Fusion Imaging
- 4.3.7 Optical Imaging
5.0 Corporate Profiles
- 5.1 Advanced Biomarker Technologies
- 5.2 Agilent Technologies
- 5.3 Avid Radiopharmaceuticals Inc.
- 5.4 Bioscan
- 5.5 Capintec Inc.
- 5.6 Cardinal Health
- 5.7 Clinical Data Inc.
- 5.8 Digirad Corp.
- 5.9 Dilon Diagnostics
- 5.10 Gamma Medica-Ideas Inc.
- 5.11 GE Healthcare
- 5.12 Hitachi Medical Systems America Inc.
- 5.13 MIR Preclinical Services
- 5.14 OptoSonics Inc.
- 5.15 Philips Healthcare
- 5.16 PhotoDetection Systems Inc.
- 5.17 Positron Corp.
- 5.18 Shimadzu Corp.
- 5.19 Siemens Healthcare
- 5.20 Spectrum Dynamics Ltd.
- 5.21 Toshiba America Medical Systems
- 5.22 UltraSPECT Ltd.
- 5.23 VisEn Medical Inc.
- 5.24 Zecotek Photonics Inc.
LIST OF EXHIBITS
- Exhibit 1: World Market for Molecular Imaging
- Exhibit 2: Key Liquid Radionuclides
- Exhibit 3: Worldwide SPECT Procedures
- Exhibit 4: US SPECT Procedures
- Exhibit 5: Worldwide PET Procedures
- Exhibit 6: US PET Procedures
- Exhibit 7: Worldwide Molecular CT Procedures
- Exhibit 8: Worldwide Molecular PET Procedures
- Exhibit 9: World Medical Market for PET Systems
- Exhibit 10: US Medical Market for PET Systems
- Exhibit 11: World Medical Market for PET Systems
- Exhibit 12: US Medical Market for PET Systems
- Exhibit 13: Worldwide Medical PET Installed Base
- Exhibit 14: World Medical Market for SPECT Systems
- Exhibit 15: US Medical Market for SPECT Systems
- Exhibit 16: World Medical Market for SPECT Systems
- Exhibit 17: US Medical Market for SPECT Systems
- Exhibit 18: Worldwide Medical SPECT Installed Base
- Exhibit 19: World Medical Market for MRI Molecular Imaging Systems
- Exhibit 20: US Medical Market for MRI Molecular Imaging Systems
- Exhibit 21: World Medical Market for CT Molecular Imaging Systems
- Exhibit 22: US Medical Market for CT Molecular Imaging Systems
- Exhibit 23: World Medical Market for Ultrasound Molecular Imaging Systems
- Exhibit 24: US Medical Market for Ultrasound Molecular Imaging Systems
- Exhibit 25: World Medical Market for PET/CT Imaging Systems
- Exhibit 26: US Medical Market for PET/CT Imaging Systems
- Exhibit 27: World Medical Market for SPECT/CT Imaging Systems
- Exhibit 28: US Medical Market for SPECT/CT Imaging Systems
